TABLE 1.
Demographic, clinical, management, and outcome data of the IIH and REF groups
| REF | IIH | Significance | |
|---|---|---|---|
| Number | 9 | 8 | |
| Gender (F/M) | 4/5 | 5/3 | X 2(1) = 0.544, p = 0.457 |
| Age (years) | 42.7 ± 18.6 | 36.4 ± 13.7 | t(15) = 0.783, p = 0.446 |
| BMI (kg/m2) | 24.9 ± 4.2 | 32.8 ± 8.2 | t(15) = 2.521, p = 0.024 |
| Co‐morbidity | |||
| Arterial hypertension, n (%) | 2 (22.2%) | 0 | |
| Diabetes mellitus, n (%) | 0 | 0 | |
| Pre‐operative symptoms | |||
| Duration of symptoms (years) | 10.6 ± 10.5 | 3.3 ± 2.1 | t(15) = 1.928, p = 0.073 |
| Headache, n (%) | 3 (33.3%) | 8 (100%) | X 2(1) = 8.242, p = 0.004 |
| Visual disturbances, n (%) | 0 (0%) | 6 (75%) | X 2(1) = 10.432, p = 0.001 |
| Dizziness, n (%) | 4 (44.4%) | 1 (12.5%) | X 2(1) = 2.082, p = 0.149 |
| Tinnitus, n (%) | 1 (11.1%) | 2 (25%) | X 2(1) = 1.639, p = 0.200 |
| Cognitive impairment, n (%) | 3 (33.3%) | 3 (37.5%) | X 2(1) = 0.032, p = 0.858 |
| ICP scores | |||
| Mean ICP, average (mmHg) | 13.4 ± 4.1 | ||
| Mean ICP, >15 mmHg (%) | 33 ± 35 | ||
| MWA, average (mmHg) | 5.9 ± 2.8 | ||
| MWA, >5 mmHg (%) | 51 ± 32 | ||
| Management | |||
| Shunt surgery, n (%) | 6 (75%) | ||
| Conservative, n (%) | 2 (25%) | ||
| Cranial surgery (epilepsy 6, aneurysm 2, tumor 1), n (%) | 9 (100%) | ||
| Outcome of treatment of IIH | |||
| Headache | |||
| Complete relief | 2 (25%) | ||
| Partial relief | 3 (37.5%) | ||
| No relief | 3 (37.5%) | ||
| Visual problems | 2 (20%) | ||
| Complete improvement | 5 (30%) | ||
| Partial improvement | 3 (50%) | ||
Categorical data presented as numbers; continuous data as mean ± standard deviation (SD). Independent samples t test for continuous data and Pearson chi‐square test for categorical data.